RCYC
NVS icon

Richard C. Young & Co’s Novartis NVS Stock Holding History

Richard C. Young & Co’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-131,600
Closed -$12.7M – 80
2024
Q1 		$12.7M Sell
131,600
-5,556
-4% -$570K 1.6% 30
2023
Q4 		$13.8M Sell
137,156
-2,967
-2% -$286K 1.86% 20
2023
Q3 		$14.3M Sell
140,123
-2,636
-2% -$268K 2.03% 16
2023
Q2 		$14.4M Buy
142,759
+322
+0.2% +$32.2K 1.98% 19
2023
Q1 		$13.1M Buy
142,437
+1,671
+1% +$146K 1.8% 25
2022
Q4 		$12.8M Sell
140,766
-392
-0.3% -$33K 1.7% 24
2022
Q3 		$10.7M Sell
141,158
-972
-0.7% -$80.6K 1.64% 23
2022
Q2 		$12M Buy
142,130
+1,724
+1% +$151K 1.56% 26
2022
Q1 		$12.3M Buy
140,406
+8,504
+6% +$736K 1.57% 27
2021
Q4 		$11.5M Sell
131,902
-5,016
-4% -$416K 1.45% 28
2021
Q3 		$11.2M Sell
136,918
-352
-0.3% -$31.7K 1.54% 29
2021
Q2 		$12.5M Buy
137,270
+3,154
+2% +$281K 1.59% 26
2021
Q1 		$11.5M Buy
134,116
+8,200
+7% +$736K 1.53% 28
2020
Q4 		$11.9M Buy
125,916
+6,809
+6% +$595K 1.81% 23
2020
Q3 		$10.4M Buy
119,107
+4,677
+4% +$405K 1.67% 21
2020
Q2 		$9.99M Sell
114,430
-2,319
-2% -$200K 1.66% 24
2020
Q1 		$9.63M Buy
116,749
+4,591
+4% +$410K 1.87% 19
2019
Q4 		$10.6M Buy
112,158
+2,411
+2% +$216K 1.77% 23
2019
Q3 		$9.54M Buy
109,747
+910
+0.8% +$81.7K 1.71% 22
2019
Q2 		$9.94M Buy
108,837
+1,317
+1% +$111K 1.88% 18
2019
Q1 		$9.26M Buy
+107,520
New +$8.63M 1.77% 19

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Richard C. Young & Co's NVS Position: Q2 2024 in Review

Richard C. Young & Co sold out of Novartis (NVS) in Q2 2024, closing a stake of 131,600 shares — an estimated $12.7M sold.

Richard C. Young & Co first reported a position in NVS in Q1 2019 and held it in 21 quarters. The position peaked at $14.4M in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • Richard C. Young & Co reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
  • Richard C. Young & Co sold 131,600 Novartis shares in Q2 2024, an estimated $12.7M.
  • Richard C. Young & Co first reported a position in Novartis in Q1 2019 and held it in 21 quarters.
  • Richard C. Young & Co's Novartis position peaked at $14.4M in Q2 2023.
  • 1,307 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Richard C. Young & Co's 13F filing for Q2 2024, filed 8 Aug 2024.